Spinal cord injuries are life-altering, often leaving individuals with severe mobility impairments. While rehabilitation robotics—devices that guide ...

Scientists at .Neurorestore (EPFL/CHUV/UNIL) have developed an approach that combines rehabilitation robotics with spinal ...

The global motion stimulation therapy market is set for significant growth, with market projections estimating its value at USD 1.4 billion in 2024. Fueled by rapid technological integration in ...

The Japanese wound care market is set to witness significant growth in the coming years, expanding at a compound annual growth rate (CAGR) of 7.59% from 2025 to 2033. According to market research, the ...

The global extracorporeal membrane oxygenation machine market is on a growth trajectory, with revenue anticipated to reach ...

Sleep Apnea Implants MarketThe global sleep apnea implants market is projected to grow at a CAGR of 3.8% from 2024 to 2035, ...

Centinel Spine signed a senior secured loan agreement with SLR Capital Partners for $60 million, according to a Feb. 26 news release.

Future technology will also address other Parkinson’s symptoms, like depression and sleep dysfunction. Credit: Neuroscience News The FDA approval covers two treatment algorithms that run on a device ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode identifier) for people with Parkinson's disease, Medtronic announced Monday. Like ...

The FDA approved the world’s first adaptive deep brain stimulator for the disease.